PET/CT vs. CT for lung biopsy
Part of Lungs & breathing clinical trials.
This study compares two ways to guide a needle biopsy in people with suspected lung cancer: using a CT scan alone or using a combined PET/CT scan. The goal is to see which method better helps doctors get a clear diagnosis with fewer needle passes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a lung spot (nodule or mass) larger than 1 cm on your CT scan that can be safely reached with a biopsy needle.
- You do not have a bleeding disorder (like hemophilia) and your blood-clotting levels (INR and platelet count) are normal.
- You are not pregnant or breastfeeding.
- You have good oxygen levels (SpO2 above 94%) and stable blood pressure.
- Your kidney function is normal (creatinine level below 2 mg/dL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to take a tissue sample (biopsy) from lung growths that sit against the chest wall: one using a CT scanner and the other using an ultrasound machine. The aim is to see which method is better at getting an accurate diagnosis.
This study compares two types of needles used in a CT-guided lung biopsy to see which one is better at diagnosing lung nodules. The trial aims to find a more accurate and safe way to obtain tissue samples from peripheral lung nodules, which could help guide treatment decisions.
This study compares two ways of doing a lung biopsy with a needle guided by ultrasound. It aims to see which method gives better samples for diagnosing lung cancer.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial tests a new way to take CT images during a lung biopsy that uses less radiation. It aims to make the procedure safer and clearer for patients.
This study tests a new microscope probe called CelTouch that doctors can use during a lung biopsy to see cells in real time, which may help diagnose lung lesions more accurately.
Hear when a new Lung Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.